Persistent Plasmodium falciparum and Plasmodium vivax infections in a western Cambodian population: implications for prevention, treatment and elimination strategies — Rupam Tripura (2016) | RDL Network
Persistent Plasmodium falciparum and Plasmodium vivax infections in a western Cambodian population: implications for prevention, treatment and elimination strategies
Malaria Journal 15(1)
Article 2016 English
Authors
RT
Rupam Tripura
TP
Thomas J. Peto
JC
Jeremy Chalk
Abstract
1 min read
Subclinical Plasmodium parasitaemia is an important reservoir for the transmission and persistence of malaria, particularly in low transmission areas. Using ultrasensitive quantitative PCR (uPCR) for the detection of parasitaemia, the entire population of three Cambodian villages in Pailin province were followed for 1 year at three-monthly intervals. A cohort of adult participants found initially to have asymptomatic malaria parasitaemia was followed monthly over the same period. The initial cross sectional survey in June 2013 (M0) of 1447 asymptomatic residents found that 32 (2.2 %) had Plasmodium falciparum, 48 (3.3 %) had P. vivax, 4 (0.3 %) had mixed infections and in 142/1447 (9.8 %) malaria was detected but there was insufficient DNA to identify the species (Plasmodium. species). Polymorphisms in the 'K13-propeller' associated with reduced susceptibility to artemisinin derivatives (C580Y) were found in 17/32 (51 %) P. falciparum strains. Monthly follow-up without treatment of 24 adult participants with asymptomatic mono or mixed P. falciparum infections found that 3/24 (13 %) remained parasitaemic for 2–4 months, whereas the remaining 21/24 (87 %) participants had cleared their parasitaemia after 1 month. In contrast, 12/34 (35 %) adult participants with P. vivax mono-infection at M0 had malaria parasites (P. vivax or P. sp.) during four or more of the following 11 monthly surveys. This longitudinal survey in a low transmission setting shows limited duration of P. falciparum carriage, but prolonged carriage of P. vivax infections. Radical treatment of P. vivax infections by 8-aminoquinoline regimens may be required to eliminate all malaria from Cambodia. Trial registration ClinicalTrials.gov NCT01872702
Thuy-Nhien Nguyen, Lorenz von Seidlein, Tuong-Vy Nguyen, Truong Le Phuc Nhi, Son Do Hung, Huong-Thu Pham, Nguyen Tam-Uyen, Thanh Dong Le, Van Hue Dao, Mavuto Mukaka, Nicholas Day, Sir Nicholas White, Arjen M. Dondorp, Guy Thwaites, Tran Tinh Hien
Koukeo Phommasone, Frank van Leth, Mallika Imwong, Gisela Henriques, Tiengkham Pongvongsa, Bipin Adhikari, Thomas J. Peto, Cholrawee Promnarate, Mehul Dhorda, Pasathorn Sirithiranont, Mavuto Mukaka, Pimnara Peerawaranun, Nicholas Day, Frank Cobelens, Arjen M. Dondorp, Paul N. Newton, Sir Nicholas White, Lorenz von Seidlein, Mayfong Mayxay
Koukeo Phommasone, Bipin Adhikari, Gisela Henriques, Tiengkham Pongvongsa, Panom Phongmany, Lorenz von Seidlein, Sir Nicholas White, Nicholas Day, Arjen M. Dondorp, Paul N. Newton, Mallika Imwong, Mayfong Mayxay
Thomas J. Peto, Sabine E. Kloprogge, Rupam Tripura, Chea Nguon, Nou Sanann, Yok Sovann, Chhouen Heng, Cholrawee Promnarate, Jeremy Chalk, Ngak Song, Sue J. Lee, Yoel Lubell, Mehul Dhorda, Mallika Imwong, Sir Nicholas White, Lorenz von Seidlein, Arjen M. Dondorp
Thomas J. Peto, Rupam Tripura, Sue J. Lee, Thomas Althaus, Susanna Dunachie, Chea Nguon, Mehul Dhorda, Cholrawee Promnarate, Jeremy Chalk, Mallika Imwong, Lorenz von Seidlein, Nicholas Day, Arjen M. Dondorp, Sir Nicholas White, Yoel Lubell
Discussion(0)
No comments yet. Be the first to comment.